Topic

Washington

A collection of 516 issues

Renewing Takhzyro (lanadelumab-flyo) Approval with Cigna in Washington: Complete Timeline & Documentation Guide

Answer Box: Takhzyro Renewal with Cigna in Washington Cigna requires renewal documentation 2-4 weeks before your current Takhzyro approval expires, typically after 6-12 months. Submit via Express Scripts with attack frequency logs showing ≥50% reduction, specialist attestation, and decreased on-demand therapy claims. If denied, Washington residents can appeal through internal
5 min read

Myths vs. Facts: Getting Trikafta Covered by UnitedHealthcare in Washington (2025 Guide)

Answer Box: Getting Trikafta Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) as a Tier 3 specialty medication dispensed through OptumRx. Approval requires documented CFTR genotype (F508del or responsive mutation), CF specialist prescription, recent baseline labs, and medical necessity letter. If denied, Washington residents
6 min read

Do You Qualify for Enhertu Coverage by UnitedHealthcare in Washington? Decision Tree & Next Steps

Answer Box UnitedHealthcare requires prior authorization (PA) for Enhertu (fam-trastuzumab deruxtecan-nxki) in Washington, mandating HER2-positive biomarker testing, specific cancer diagnoses, and evidence of prior HER2-targeted therapy failure. Submit PA via the UnitedHealthcare Provider Portal with pathology reports, treatment history, and oncologist letter. If denied, Washington residents can appeal internally (60
5 min read

Getting Bavencio (Avelumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Bavencio Covered by Blue Cross Blue Shield in Washington Bavencio (avelumab) requires prior authorization from Blue Cross Blue Shield plans in Washington for FDA-approved uses—metastatic Merkel cell carcinoma and maintenance urothelial carcinoma. Submit PA requests via provider portal or fax with diagnosis codes, staging, prior platinum
6 min read

How to Get Rezlidhia (Olutasidenib) Covered by Cigna in Washington: Prior Authorization Forms, Appeals Process & Success Strategies

Answer Box: Getting Started Today Cigna requires prior authorization for Rezlidhia (olutasidenib) in Washington for adults ≥18 with relapsed/refractory AML and confirmed IDH1 mutation via FDA-approved testing. Submit through ExpressPAth or CoverMyMeds with mutation results, diagnosis documentation, and treatment history. If denied, you have 180 days to appeal internally,
5 min read

How to Get HyperHEP (Hepatitis B Immune Globulin) Covered by UnitedHealthcare in Washington: Complete Timeline & Appeals Guide

Quick Answer: Getting HyperHEP Covered by UnitedHealthcare in Washington HyperHEP (hepatitis B immune globulin) requires prior authorization from UnitedHealthcare for post-exposure prophylaxis. Submit via the UHC provider portal within 24-48 hours of exposure with documented HBsAg+ source, patient susceptibility (anti-HBs <10 mIU/mL), and CDC timing guidelines. Standard approvals
6 min read